High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.9M
$10,892,486
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
10b5-1 Sell
|
2026-03-20 | $199,516 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Azamian Bobak R.
• CEO
Sell to CoverΔOwn -26.4%
2026-03-19
$801,588
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
CEO
Sell to CoverΔOwn -26.4%
|
2026-03-19 | $801,588 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Farrow Jeffrey S
• Officer • See Remarks
Sell to Cover
2026-03-19
$146,462
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-19 | $146,462 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2026-03-19
$26,130
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-19 | $26,130 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Mottiwala Aziz
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-19
$297,480
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-19 | $297,480 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-19 | $307,463 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Wahl Bryan
• Officer • General Counsel
Sell to Cover
2026-03-19
$283,477
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-03-19 | $283,477 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Whitfield Dianne C.
• Officer • Chief Human Resources Officer
Sell to CoverΔOwn -10.7%
2026-03-19
$279,658
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Human Resources Officer
Sell to CoverΔOwn -10.7%
|
2026-03-19 | $279,658 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Azamian Bobak R.
• CEO
Sell to CoverΔOwn -20.4%
2026-03-18
$801,640
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
CEO
Sell to CoverΔOwn -20.4%
|
2026-03-18 | $801,640 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Farrow Jeffrey S
• Officer • See Remarks
Sell to Cover
2026-03-18
$146,558
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-18 | $146,558 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2026-03-18
$26,041
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-18 | $26,041 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Mottiwala Aziz
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-18
$297,514
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-18 | $297,514 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-18 | $248,043 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Wahl Bryan
• Officer • General Counsel
Sell to Cover
2026-03-18
$283,429
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-03-18 | $283,429 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Whitfield Dianne C.
• Officer • Chief Human Resources Officer
Sell to Cover
2026-03-18
$279,718
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Human Resources Officer
Sell to Cover
|
2026-03-18 | $279,718 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Azamian Bobak R.
• CEO
Sell to CoverΔOwn -16.1%
2026-03-17
$761,676
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
CEO
Sell to CoverΔOwn -16.1%
|
2026-03-17 | $761,676 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Farrow Jeffrey S
• Officer • See Remarks
Sell to Cover
2026-03-17
$146,546
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-17 | $146,546 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2026-03-17
$26,032
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-17 | $26,032 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Mottiwala Aziz
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-17
$297,534
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-17 | $297,534 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-17 | $216,938 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Wahl Bryan
• Officer • General Counsel
Sell to Cover
2026-03-17
$283,511
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-03-17 | $283,511 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Whitfield Dianne C.
• Officer • Chief Human Resources Officer
Sell to Cover
2026-03-17
$279,693
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Human Resources Officer
Sell to Cover
|
2026-03-17 | $279,693 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $859,819x3 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Neervannan Seshadri
• COO
10b5-1 SellΔOwn -10.6%
2026-03-04
$641,421
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
10b5-1 SellΔOwn -10.6%
|
2026-03-04 | $641,421 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2025-12-16
$165,201
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-12-16 | $165,201 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Whitfield Dianne C.
• Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -16.0%
2025-12-16
$592,500
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -16.0%
|
2025-12-16 | $592,500 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
LINK WILLIAM J PHD
• Director
10b5-1 Sell
2025-12-15
$1,864,678Largex5
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-15 | $1,864,678Largex5 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2025-09-24 | $332,220 | S | Form 4 |